Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.01 - $9.46 $2.3 Million - $4.35 Million
459,900 New
459,900 $4.14 Million
Q3 2023

Nov 13, 2023

SELL
$15.96 - $22.18 $1.46 Million - $2.03 Million
-91,300 Closed
0 $0
Q2 2023

Aug 14, 2023

SELL
$15.65 - $24.1 $1.43 Million - $2.2 Million
-91,300 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$17.48 - $29.09 $2.48 Million - $4.12 Million
141,700 New
141,700 $2.5 Million
Q4 2022

Feb 14, 2023

BUY
$17.09 - $27.91 $2.42 Million - $3.95 Million
141,700 New
141,700 $3.85 Million
Q3 2022

Nov 13, 2023

BUY
$15.6 - $21.15 $1.42 Million - $1.93 Million
91,300 New
91,300 $1.58 Million
Q2 2022

Aug 14, 2023

BUY
$13.32 - $19.98 $1.22 Million - $1.82 Million
91,300 New
91,300 $1.6 Million
Q1 2022

May 12, 2023

BUY
$15.24 - $29.75 $7.01 Million - $13.7 Million
459,745 Added 324.45%
601,445 $10.2 Million
Q1 2022

May 09, 2022

SELL
$15.24 - $29.75 $9.17 Million - $17.9 Million
-601,445 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$25.43 - $34.25 $15.3 Million - $20.6 Million
601,445 New
601,445 $16.3 Million
Q3 2021

Nov 14, 2022

BUY
$28.98 - $39.54 $17.4 Million - $23.8 Million
601,445 New
601,445 $17.8 Million
Q3 2021

Nov 05, 2021

SELL
$28.98 - $39.54 $17.4 Million - $23.8 Million
-601,445 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$28.5 - $39.37 $17.1 Million - $23.7 Million
601,445 New
601,445 $23.1 Million
Q2 2021

Aug 10, 2021

SELL
$28.5 - $39.37 $17.1 Million - $23.7 Million
-601,445 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$30.22 - $45.57 $18.2 Million - $27.4 Million
601,445 New
601,445 $18.4 Million
Q1 2021

May 07, 2021

SELL
$30.22 - $45.57 $22.7 Million - $34.3 Million
-751,806 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$23.5 - $52.65 $17.7 Million - $39.6 Million
751,806 New
751,806 $28.7 Million
Q4 2020

Feb 10, 2021

SELL
$23.5 - $52.65 $22.5 Million - $50.4 Million
-958,000 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$18.85 - $27.0 $18.1 Million - $25.9 Million
958,000 New
958,000 $22.1 Million
Q3 2020

Nov 10, 2020

SELL
$18.85 - $27.0 $17.1 Million - $24.4 Million
-904,700 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$9.76 - $25.95 $8.83 Million - $23.5 Million
904,700 New
904,700 $22.5 Million
Q2 2020

Aug 07, 2020

SELL
$9.76 - $25.95 $5.71 Million - $15.2 Million
-585,000 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$8.9 - $19.08 $5.21 Million - $11.2 Million
585,000 New
585,000 $5.83 Million
Q1 2020

May 08, 2020

SELL
$8.9 - $19.08 $5.21 Million - $11.2 Million
-585,000 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$11.61 - $17.21 $6.79 Million - $10.1 Million
585,000 New
585,000 $8.4 Million
Q4 2019

Feb 12, 2020

SELL
$11.61 - $17.21 $3.89 Million - $5.77 Million
-335,000 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$10.01 - $16.87 $3.35 Million - $5.65 Million
335,000 New
335,000 $4.66 Million
Q3 2019

Nov 08, 2019

SELL
$10.01 - $16.87 $3.35 Million - $5.65 Million
-335,000 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$12.51 - $17.28 $4.19 Million - $5.79 Million
335,000 New
335,000 $4.91 Million
Q2 2019

Aug 09, 2019

SELL
$12.51 - $17.28 $4.19 Million - $5.79 Million
-335,000 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$9.97 - $15.57 $3.34 Million - $5.22 Million
335,000 New
335,000 $3.35 Million
Q4 2018

Feb 08, 2019

SELL
$9.97 - $15.57 $3.34 Million - $5.22 Million
-335,000 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$14.99 - $22.14 $5.02 Million - $7.42 Million
335,000 New
335,000 $5.39 Million

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.